This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Randomized, Open Label, Multicenter, Phase II, 2...
Clinical trial

A Randomized, Open Label, Multicenter, Phase II, 2-Arm Study comparing the conventional 3 weekly schedule of Jevtana (Cabazitaxel) with a weekly regimen in patients with Metastastic Castration Resistant Prostate CancerConWeCab

Read time: 1 mins
Last updated:19th Dec 2011
To determine if a weekly regime improves tolerability of cabazitaxel compared to the standard 3 week regimen
Category Value
Study start date 2011-12-19

View full details